Long-term Stimulant Treatment of Children With Attention-Deficit Hyperactivity Disorder Symptoms: A Randomized, Double-blind, Placebo-Controlled Trial
The DOI matches its Crossref record, with a small difference in title or year; 26 of the 26 references it cites were found in a registry or an index.
Abstract
BACKGROUND: We wanted to study the effects of amphetamine on symptoms of attention-deficit hyperactivity disorder (ADHD) over a longer period than has been reported in previous studies of central stimulants in this condition. METHODS: Sixty-two children, aged 6 to 11 years, meeting DSM-III-R symptom criteria for ADHD participated in a parallel-group design, randomized, double-blind, placebo-controlled study of amphetamine treatment. Treatment was not restricted to children with "pure" ADHD, ie, some had comorbid diagnoses. In the amphetamine group, children received active treatment for 15 months. RESULTS: Amphetamine was clearly superior to placebo in reducing inattention, hyperactivity, and other disruptive behavior problems and tended to lead to improved results on the Wechsler Intelligence Scale for Children--Revised. Treatment failure rate was considerably lower and time to treatment failure was longer in the amphetamine group. Adverse effects were few and relatively mild. CONCLUSION: The results of this long-term, placebo-controlled study of the central stimulant amphetamine in the treatment of ADHD indicate that there are remaining positive effects of the drug 15 months after starting treatment.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Fourth, as the study by Styck and Watkins (2014) did not consider the medication status of participants, it cannot be ruled out that their findings were not confounded by medication effects, as long-term use of medication has been shown to influence the IQ of children with ADHD (Gillberg et al., 1997; Gimpel et al., 2005).”
From Structure of the Wechsler Intelligence Scale for Children – Fourth Edition in a Group of Children with ADHD (2016) · cites this paper as Gillberg et al., 1997
In the citing paper
“In ASD and attention deficit hyperactivity disorder, improvement in measures of cognitive processing (verbal learning and cancellation task) and IQ have been reported in pharmacological RCTs after 3–12 months of treatment and behavioural interventions88–91.”
From Drug development for neurodevelopmental disorders: lessons learned from fragile X syndrome (2018) · cites this paper as [91]
In the citing paper
“Evidence of cognitive improvement has not yet been unequivocally demonstrated in RCTs that evaluate pharmacological treatments in NDDs.”
From Drug development for neurodevelopmental disorders: lessons learned from fragile X syndrome (2018) · cites this paper as [91]
In the citing paper
“However, these studies were conducted in individuals who were intellectually higher functioning than typical male patients with FXS.”
From Drug development for neurodevelopmental disorders: lessons learned from fragile X syndrome (2018) · cites this paper as [91]
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders, Third Edition, Revised
Kobylski, T. P. (1988) · Psychosomatics · doi:10.1016/s0033-3182(88)72438-x · Cited by 1,054
THE BEHAVIOR OF CHILDREN RECEIVING BENZEDRINE
Bradley, C. (1937) · American Journal of Psychiatry · doi:10.1176/ajp.94.3.577 · Cited by 1,035
Birleson, P. (1981) · Journal of Child Psychology and Psychiatry · doi:10.1111/j.1469-7610.1981.tb00533.x · Cited by 859
ADHD in the Schools: Assessment and Intervention Strategies
DuPaul, G. J., & Stoner, G. D. (1994) · Cited by 756
Hyperactive Children: A Handbook for Diagnosis and Treatment
Barkley, R. A. (1981) · Medical Entomology and Zoology · Cited by 678
Methylphenidate and dextroamphetamine treatments of hyperactivity: Are there true nonresponders?
Elia, J., Borcherding, B. G., Rapoport, J. L., & Keysor, C. S. (1991) · Psychiatry Research · doi:10.1016/0165-1781(91)90126-a · Cited by 294
Use of methylphenidate in the treatment of children with autistic disorder
Quintana, H., Birmaher, B., Stedge, D., Lennon, S., Freed, J., Bridge, J., & Greenhill, L. (1995) · Journal of Autism and Developmental Disorders · doi:10.1007/bf02179289 · Cited by 217
Taylor, E., Schachar, R., Thorley, G., Wieselberg, H. M., Everitt, B., & Rutter, M. (1987) · Psychological Medicine · doi:10.1017/s0033291700013039 · Cited by 210
Landgren, M., Pettersson, R., Kjellman, B., & Gillberg, C. (1996) · Developmental Medicine & Child Neurology · doi:10.1111/j.1469-8749.1996.tb15046.x · Cited by 191
Self-citationEffect of long-term treatment of hyperactive children with methylphenidate.
Weiss, G., Kruger, E., Danielson, U., & Elman, M. (1975) · PubMed Central · Cited by 173
Jacobvitz, D. B., Sroufe, L. A., STEWART, M., & Leffert, N. (1990) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199009000-00001 · Cited by 171
Douglas, V. I., Barr, R. G., O'Neill, M. E., & Britton, B. G. (1986) · Journal of Child Psychology and Psychiatry · doi:10.1111/j.1469-7610.1986.tb02283.x · Cited by 161
Hyperactive Boys Almost Grown Up: III. Methylphenidate Effects on Ultimate Height
Klein, R. G. (1988) · Archives of General Psychiatry · doi:10.1001/archpsyc.1988.01800360079012 · Cited by 155
Three-year multimodality treatment study of 100 hyperactive boys
Satterfield, J. H., Satterfield, B. T., & Cantwell, D. P. (1981) · The Journal of Pediatrics · doi:10.1016/s0022-3476(81)80788-3 · Cited by 151
Tricyclic Antidepressant and Methylphenidate Treatment of Attention Deficit Disorder in Children
Garfinkel, B. D., Wender, P. H., Sloman, L., & O'NEIL, I. (1983) · Journal of the American Academy of Child Psychiatry · doi:10.1016/s0002-7138(09)60669-5 · Cited by 129
Children With Preschool Minor Neurodevelopmental Disorders, V: Neurodevelopmental Profiles At Age 13
Gillberg, I. C., Gillberg, C., & Groth, J. (1989) · Developmental Medicine & Child Neurology · doi:10.1111/j.1469-8749.1989.tb08407.x · Cited by 125
Self-citationA 2-YEAR FOLLOW-UP OF 72 HYPERACTIVE BOYS: CLASSROOM BEHAVIOR AND PEER ACCEPTANCE
RIDDLE, K. D., & RAPOPORT, J. L. (1976) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-197602000-00007 · Cited by 100
GADOW, K. D., NOLAN, E., SPRAFKIN, J., & SVERD, J. (1995) · Journal of Developmental & Behavioral Pediatrics · doi:10.1097/00004703-199506000-00004 · Cited by 94
Stevenson, R. D., & Wolraich, M. L. (1989) · Pediatric Clinics of North America · doi:10.1016/s0031-3955(16)36764-5 · Cited by 86
Textbook of pharmacotherapy for child and adolescent psychiatric disorders
Rosenberg, D., Holttum, J. R., & Gershon, S. (1994) · Medical Entomology and Zoology · Cited by 82
Using Psychostimulants to Treat Behavioral Disorders of Children and Adolescents
Dulcan, M. K. (1990) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.1990.1.7 · Cited by 73
METHYLPHENDATE AND ADHD: INFLUENCE OF AGE, IQ AND NEURODEVELOPMENTAL STATUS
Mayes, S. D., Crites, D. L., Bixler, E. O., Humphrey, F. J., & Maltison, R. E. (1994) · Developmental Medicine & Child Neurology · doi:10.1111/j.1469-8749.1994.tb11811.x · Cited by 70
Prediction of Response to Methylphenidate among Children with ADHD and Mental Retardation
Handen, B. L., Janosky, J. E., McAuliffe, S., Breaux, A. M., & Feldman, H. M. (1994) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199410000-00014 · Cited by 54
Sebrechts, M. M., Shaywitz, S. E., Shaywitz, B. A., Jatlow, P., Anderson, G. M., & Cohen, D. J. (1986) · Pediatrics · doi:10.1542/peds.77.2.222 · Cited by 42
DuPaul, G. J., & Barkley, R. A. (1993) · Behavior Therapy · doi:10.1016/s0005-7894(05)80256-4 · Cited by 37
Family abuse of methylphenidate.
Fulton, A. I., & Yates, W. R. (1988) · PubMed · Cited by 20
Cited by
(1999) · Archives of General Psychiatry · doi:10.1001/archpsyc.56.12.1073 · Cited by 3,372
Pliszka, S. (2007) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/chi.0b013e318054e724 · Cited by 1,765
Emotion Dysregulation in Attention Deficit Hyperactivity Disorder
Shaw, P., Stringaris, A., Nigg, J., & Leibenluft, E. (2014) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2013.13070966 · Cited by 1,232
Greenhill, L. L., Pliszka, S., & Dulcan, M. K. (2002) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200202001-00003 · Cited by 927
Misuse and Diversion of Stimulants Prescribed for ADHD: A Systematic Review of the Literature
WILENS, T. E., ADLER, L. A., ADAMS, J., SGAMBATI, S., ROTROSEN, J., SAWTELLE, R., UTZINGER, L., & FUSILLO, S. (2008) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/chi.0b013e31815a56f1 · Cited by 824
Metadata
- Authors
- Gillberg, C.
- Affiliations
- University of Gothenburg (SE)
- Corresponding author
- Gillberg, Christopher
- Venue
- Archives of General Psychiatry
- Publisher
- American Medical Association (AMA)
- Published
- 1997-09-01
- Volume
- 54
- Issue
- 9
- Pages
- 857
- ISSN
- 0003-990X (ISSN-L)
- OpenAlex
- W2158377281
- Cited by
- 340
- References
- 26
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 6 · 2023: 3 · 2022: 2 · 2021: 7 · 2020: 3 · 2019: 5 · 2018: 2 · 2017: 9 · 2016: 6 · 2015: 8 · 2014: 10 · 2013: 7 · 2012: 15
- FWCI
- 14.40
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Archives of General Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
- Social Sciences › Psychology › Developmental and Educational Psychology › Behavioral and Psychological Studies
- Social Sciences › Psychology › Neuropsychology and Physiological Psychology › Developmental and Educational Neuropsychology
- Keywords
- attention deficit hyperactivity disorder, amphetamine, central stimulants, long-term treatment, children, inattention, hyperactivity, disruptive behavior, intelligence, treatment failure, adverse effects, comorbidities
- MeSH terms
- Amphetamine, Central Nervous System Stimulants, Attention Deficit Disorder with Hyperactivity, Bipolar Disorder, Child, Double-Blind Method, Female, Follow-Up Studies, Headache, Humans, Male, Placebos, Sleep Wake Disorders, Wechsler Scales, Abdominal Pain, Comorbidity, Treatment Outcome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.